DSM-Firmenich names Noviwest and Panavora. DSM-Firmenich stock trades EUR 108.80
Published on 10/24/2026 at 10:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBusiness separation details
- dsm-firmenich announced the Noviwest and Panavora names on October 22, 2026.
- DSM-Firmenich stock traded at EUR 108.80 at 10:14 a.m. CEST on October 24, 2026.
- The next Xetra session is scheduled for October 26, 2026.
DSM-Firmenich announced Noviwest and Panavora as the names of two standalone companies linked to the planned sale of its Animal Nutrition & Health business to CVC Capital Partners on October 22, 2026, according to the dsm-firmenich release. At 10:14 a.m. CEST on October 24, 2026, the stock traded at EUR 108.80 in weekend trading at Lang & Schwarz.
Market context: Market report SMI.
Weekend trading
The Lang & Schwarz quote was EUR 108.80 at 10:14 a.m. CEST on October 24, 2026. Xetra and the primary exchanges are closed for the current session. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CET/CEST is shown by the continuously updated real-time quote of DSM-Firmenich stock.
Planned business separation
Under the planned transaction, CVC would acquire the companies, while dsm-firmenich would retain a 20% equity interest in each. Completion remains subject to regulatory approvals, employee consultation processes and other conditions described in the company’s February 9, 2026 announcement, the release said.
Noviwest is intended to focus on vitamins, carotenoids and aroma ingredients. Panavora is intended to focus on animal-nutrition solutions, including feed additives, services and digital products. Until completion, Animal Nutrition & Health remains part of dsm-firmenich.
Next Xetra session
The next Xetra session is scheduled for October 26, 2026. The October 22 announcement said further information would be communicated as the two future companies take shape and transaction milestones are reached.
